Clinical Trial Update: Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with or without radiation for high-risk Hodgkin lymphoma. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Hodgkin Disease | Phase 2 | Status: TERMINATED